经尿道前列腺等离子双极电切治疗高危良性前列腺增生症的临床疗效观察

目的 评价经尿道前列腺等离子双极电切术治疗高危良性前列腺增生症的临床疗效和安全性.方法 选择我院泌尿外科2010年12月至2012年12月收治的68例良性前列腺增生症患者为研究对象,运用随机数字表法将其分为对照组和观察组,每组各34例,对照组患者给予经尿道前列腺电切术治疗,而观察组患者则采用经尿道前列腺等离子双极电切术治疗,比较两组患者最大尿流率（Qmax）、并发症发生率、国际前列腺症状评分（IPSS）和生活质量评分（QOL）.结果 观察组患者并发症发生率为26.47％,明显低于对照组患者的5.88％,差异有统计学意义（P＜0.05）,入组时,两组患者的IPSS、QOL和Qmax差异无统计学意义（P＞0.05）,但两个月后,两组患者的IPSS、QOL和Qmax均优于入组时,且观察组患者改善程度明显大于对照组,差异有统计学意义（P＜0.05）.结论 经尿道前列腺等离子双极电切术治疗高危良性前列腺增生症患者临床疗效确切,术后并发症少,IPSS、QOL和Qmax改善明显,优于经尿道前列腺电切术.

Clinical effect of bipolar plasmakinetic transurethral resection of prostate in the treatment of high-risk patients with benign prostatic hyperplasia

Objective To explore and analyze the clinical effect and safety of bipolar plasmakinetic transure- thral resection of prostate in the treatment of high-risk patients with benign prostatic hyperplasia. Methods Six- W-eight patients of benign prostatic hyperplasia in the Department of Urology in our hospital from December 2010 to December 2012 were treated as the research subjects, which were divided into the control group and the observation group based on the random number table, with 34 cases in each group. Patients in the control group were treated by tmns- urethral resection of prostate for treatment of urinary tract, and those in the observation group were treated by bipolar plas- makinetic transurethral resection of prostate. The two groups were compared in maximal urinary flow rate （Q~）, the rate of complications, International Prostate Symptom Score （IPSS）, and quality of life score （QOL）. Results In the observation group, the incidence of complications was 26.47%, significantly lower than that in the control group （5.88%）, P〈0.05. Before treatment, the two groups showed no statistically significant difference in IPSS, QOL and Q~ （P〉0.050, but 2 months later, IPSS, QOL and Q~ were all significantly improved, and the improvements in the observation group was more profound （P〈0.05）. Conclusion Bipolar plasmakinetic transurethral resection of prostate has significant clini- cal effect for treatment of benign prostatic hyperplasia, with less postoperative complications, improved IPSS, QOL and Qmax, which were significantly better than transurethral resection of pros